EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

The article describes a case with a severe course of oligoarticular juvenile idiopathic arthritis with the development of contracture and destructive articular alterations. The successful use of methotrexate (15mg/m2 of body surface per week, subcutaneously) in a child with early arthritis (disease...

Full description

Bibliographic Details
Main Authors: T. V. Sleptsova, E. I. Alexeeva, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2013-04-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
children
juvenile idiopathic arthritis
methotrexate
subcutaneous introduction
Online Access:https://www.pedpharma.ru/jour/article/view/244
id doaj-6f007324a4de465e88704c9792777a4b
record_format Article
spelling doaj-6f007324a4de465e88704c9792777a4b2021-07-28T16:32:25ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892013-04-0110212112610.15690/pf.v10i2.654244EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIST. V. Sleptsova0E. I. Alexeeva1T. M. Bzarova2K. B. Isaeva3E. V. Mitenko4Scientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian Federation Sechenov First Moscow State Medical University, Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationThe article describes a case with a severe course of oligoarticular juvenile idiopathic arthritis with the development of contracture and destructive articular alterations. The successful use of methotrexate (15mg/m2 of body surface per week, subcutaneously) in a child with early arthritis (disease duration – less than 2 years) is described: 6 months after the therapy had started, acute inflammatory articular alterations, arthralgiae, morning stiffness terminated; in 12 months the range of motions in the affected joints recovered completely. The inactive disease phase and remission were registered in 6 and 12 months, accordingly. The remission has continued for 12 months.https://www.pedpharma.ru/jour/article/view/244childrenjuvenile idiopathic arthritismethotrexatesubcutaneous introduction
collection DOAJ
language English
format Article
sources DOAJ
author T. V. Sleptsova
E. I. Alexeeva
T. M. Bzarova
K. B. Isaeva
E. V. Mitenko
spellingShingle T. V. Sleptsova
E. I. Alexeeva
T. M. Bzarova
K. B. Isaeva
E. V. Mitenko
EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Pediatričeskaâ Farmakologiâ
children
juvenile idiopathic arthritis
methotrexate
subcutaneous introduction
author_facet T. V. Sleptsova
E. I. Alexeeva
T. M. Bzarova
K. B. Isaeva
E. V. Mitenko
author_sort T. V. Sleptsova
title EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
title_short EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
title_full EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
title_fullStr EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
title_full_unstemmed EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
title_sort experience of using methotrexate in a patient with early oligoarticular juvenile idiopathic arthritis
publisher Paediatrician Publishers, LLC
series Pediatričeskaâ Farmakologiâ
issn 1727-5776
2500-3089
publishDate 2013-04-01
description The article describes a case with a severe course of oligoarticular juvenile idiopathic arthritis with the development of contracture and destructive articular alterations. The successful use of methotrexate (15mg/m2 of body surface per week, subcutaneously) in a child with early arthritis (disease duration – less than 2 years) is described: 6 months after the therapy had started, acute inflammatory articular alterations, arthralgiae, morning stiffness terminated; in 12 months the range of motions in the affected joints recovered completely. The inactive disease phase and remission were registered in 6 and 12 months, accordingly. The remission has continued for 12 months.
topic children
juvenile idiopathic arthritis
methotrexate
subcutaneous introduction
url https://www.pedpharma.ru/jour/article/view/244
work_keys_str_mv AT tvsleptsova experienceofusingmethotrexateinapatientwithearlyoligoarticularjuvenileidiopathicarthritis
AT eialexeeva experienceofusingmethotrexateinapatientwithearlyoligoarticularjuvenileidiopathicarthritis
AT tmbzarova experienceofusingmethotrexateinapatientwithearlyoligoarticularjuvenileidiopathicarthritis
AT kbisaeva experienceofusingmethotrexateinapatientwithearlyoligoarticularjuvenileidiopathicarthritis
AT evmitenko experienceofusingmethotrexateinapatientwithearlyoligoarticularjuvenileidiopathicarthritis
_version_ 1721266090933223424

Similar Items